Literature DB >> 29246797

IL-1β Production by Intermediate Monocytes Is Associated with Immunopathology in Cutaneous Leishmaniasis.

Daniela Santos1, Taís M Campos1, Maíra Saldanha2, Sergio C Oliveira3, Mauricio Nascimento1, Dario S Zamboni4, Paulo R Machado5, Sérgio Arruda2, Phillip Scott6, Edgar M Carvalho7, Lucas P Carvalho8.   

Abstract

Cutaneous leishmaniasis due to Leishmania braziliensis infection is an inflammatory disease in which skin ulcer development is associated with mononuclear cell infiltrate and high levels of inflammatory cytokine production. Recently, NLRP3 inflammasome activation and IL-1β production have been associated with increased pathology in murine cutaneous leishmaniasis. We hypothesized that cutaneous leishmaniasis patients have increased expression of NLRP3, leading to high levels of IL-1β production. In this article we show high production of IL-1β in biopsy samples and Leishmania antigen-stimulated peripheral blood mononuclear cells from patients infected with L. braziliensis and reduced IL-1β levels after cure. IL-1β production positively correlated with the area of necrosis in lesions and duration of the lesions. The main source of IL-1β was intermediate monocytes (CD14++CD16+). Furthermore, our murine experiments show that IL-1β production in response to L. braziliensis was dependent on NLRP3, caspase-1, and caspase-recruiting domain (ASC). Additionally, we observed an increased expression of the NLRP3 gene in macrophages and the NLRP3 protein in intermediate monocytes from cutaneous leishmaniasis patients. These results identify an important role for human intermediate monocytes in the production of IL-1β, which contributes to the immunopathology observed in cutaneous leishmaniasis patients.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29246797      PMCID: PMC5912958          DOI: 10.1016/j.jid.2017.11.029

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  55 in total

1.  Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis.

Authors:  Lis R V Antonelli; Walderez O Dutra; Roque P Almeida; Olivia Bacellar; Edgar M Carvalho; Kenneth J Gollob
Journal:  Immunol Lett       Date:  2005-11-15       Impact factor: 3.685

2.  CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.

Authors:  Norikuni Kawanaka; Masahiro Yamamura; Tetsushi Aita; Yoshitaka Morita; Akira Okamoto; Masanori Kawashima; Mitsuhiro Iwahashi; Akiko Ueno; Yasukazu Ohmoto; Hirofumi Makino
Journal:  Arthritis Rheum       Date:  2002-10

3.  The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.

Authors:  Vijay A K Rathinam; Zhaozhao Jiang; Stephen N Waggoner; Shruti Sharma; Leah E Cole; Lisa Waggoner; Sivapriya Kailasan Vanaja; Brian G Monks; Sandhya Ganesan; Eicke Latz; Veit Hornung; Stefanie N Vogel; Eva Szomolanyi-Tsuda; Katherine A Fitzgerald
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

4.  The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients.

Authors:  G Fingerle; A Pforte; B Passlick; M Blumenstein; M Ströbel; H W Ziegler-Heitbrock
Journal:  Blood       Date:  1993-11-15       Impact factor: 22.113

5.  Cytokine profile and pathology in human leishmaniasis.

Authors:  A Ribeiro-de-Jesus; R P Almeida; H Lessa; O Bacellar; E M Carvalho
Journal:  Braz J Med Biol Res       Date:  1998-01       Impact factor: 2.590

6.  Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.

Authors:  Paulo R Machado; Julia Ampuero; Luiz H Guimarães; Leonardo Villasboas; Ana T Rocha; Albert Schriefer; Rosana S Sousa; Anette Talhari; Gerson Penna; Edgar M Carvalho
Journal:  PLoS Negl Trop Dis       Date:  2010-12-21

7.  Genomic profiling of human Leishmania braziliensis lesions identifies transcriptional modules associated with cutaneous immunopathology.

Authors:  Fernanda O Novais; Lucas P Carvalho; Sara Passos; David S Roos; Edgar M Carvalho; Phillip Scott; Daniel P Beiting
Journal:  J Invest Dermatol       Date:  2014-07-18       Impact factor: 8.551

8.  Characterization of the Histopathologic Features in Patients in the Early and Late Phases of Cutaneous Leishmaniasis.

Authors:  Maíra G Saldanha; Adriano Queiroz; Paulo Roberto L Machado; Lucas P de Carvalho; Phillip Scott; Edgar M de Carvalho Filho; Sérgio Arruda
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

9.  Protective and pathologic immune responses in human tegumentary leishmaniasis.

Authors:  Lucas P Carvalho; Sara Passos; Albert Schriefer; Edgar M Carvalho
Journal:  Front Immunol       Date:  2012-10-04       Impact factor: 7.561

Review 10.  Blood Monocytes and Their Subsets: Established Features and Open Questions.

Authors:  Loems Ziegler-Heitbrock
Journal:  Front Immunol       Date:  2015-08-17       Impact factor: 7.561

View more
  23 in total

Review 1.  Inflammasomes and Leishmania: in good times or bad, in sickness or in health.

Authors:  Dario S Zamboni; David L Sacks
Journal:  Curr Opin Microbiol       Date:  2019-06-20       Impact factor: 7.934

Review 2.  Reconciling protective and pathogenic roles of the NLRP3 inflammasome in leishmaniasis.

Authors:  Valerie Harrington; Prajwal Gurung
Journal:  Immunol Rev       Date:  2020-06-20       Impact factor: 12.988

3.  Impaired Th1 Response Is Associated With Therapeutic Failure in Patients With Cutaneous Leishmaniasis Caused by Leishmania braziliensis.

Authors:  Augusto M Carvalho; Luiz H Guimarães; Rúbia Costa; Maíra G Saldanha; Iana Prates; Lucas P Carvalho; Sérgio Arruda; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2021-02-13       Impact factor: 5.226

4.  Glyburide, a NLRP3 Inhibitor, Decreases Inflammatory Response and Is a Candidate to Reduce Pathology in Leishmania braziliensis Infection.

Authors:  Augusto M Carvalho; Fernanda O Novais; Camilla S Paixão; Camila I de Oliveira; Paulo Roberto Lima Machado; Lucas P Carvalho; Phillip Scott; Edgar M Carvalho
Journal:  J Invest Dermatol       Date:  2019-06-25       Impact factor: 8.551

5.  Transcriptomic landscape of skin lesions in cutaneous leishmaniasis reveals a strong CD8+ T cell immunosenescence signature linked to immunopathology.

Authors:  Carlos Henrique Fantecelle; Luciana Polaco Covre; Renan Garcia de Moura; Herbert Leonel de Matos Guedes; Camila Farias Amorim; Phillip Scott; David Mosser; Aloisio Falqueto; Arne N Akbar; Daniel Claudio Oliveira Gomes
Journal:  Immunology       Date:  2021-09-01       Impact factor: 7.397

Review 6.  Cytokines and Signaling Networks Regulating Disease Outcomes in Leishmaniasis.

Authors:  Amrita Saha; Souravi Roy; Anindita Ukil
Journal:  Infect Immun       Date:  2022-07-11       Impact factor: 3.609

7.  Granzyme B Produced by Natural Killer Cells Enhances Inflammatory Response and Contributes to the Immunopathology of Cutaneous Leishmaniasis.

Authors:  Taís M Campos; Fernanda O Novais; Maíra Saldanha; Rúbia Costa; Morgana Lordelo; Daniela Celestino; Camilla Sampaio; Natália Tavares; Sérgio Arruda; Paulo Machado; Cláudia Brodskyn; Phillip Scott; Edgar M Carvalho; Lucas P Carvalho
Journal:  J Infect Dis       Date:  2020-03-02       Impact factor: 5.226

8.  Transcriptional analysis of THP-1 cells infected with Leishmania infantum indicates no activation of the inflammasome platform.

Authors:  Mariana Gatto; Patrícia Aparecida Borim; Ivan Rodrigo Wolf; Taís Fukuta da Cruz; Gustavo Augusto Ferreira Mota; Aline Márcia Marques Braz; Bárbara Casella Amorim; Guilherme Targino Valente; Marjorie de Assis Golim; James Venturini; João Pessoa Araújo Junior; Alessandra Pontillo; Alexandrina Sartori
Journal:  PLoS Negl Trop Dis       Date:  2020-01-21

9.  The Leishmania antigen-specific pro-inflammatory response in cutaneous leishmaniasis is linked to disease progression but not to the therapeutic failure of pentavalent antimonials.

Authors:  Mônica Franca; Luiz H Guimarães; Maurício T Nascimento; Paulo N Rocha; Lucas P Carvalho
Journal:  Microbes Infect       Date:  2021-07-21       Impact factor: 2.700

10.  Evaluation of the Ability of Miltefosine Associated with Topical GM-CSF in Modulating the Immune Response of Patients with Cutaneous Leishmaniasis.

Authors:  Fábio Peixoto; Maurício T Nascimento; Rúbia Costa; Juliana Silva; Gaby Renard; Luiz Henrique Guimarães; Gerson Penna; Manoel Barral-Netto; Lucas P Carvalho; Paulo R L Machado; Edgar M Carvalho
Journal:  J Immunol Res       Date:  2020-08-06       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.